Резюме. В работе исследовали уровень спонтанной и митоген-индуцированной продукции ци-токинов (IL-1β, IL-4, IL-6, IL-10 и IFNγ) клетками крови 24 мужчин с нестабильной стенокардией (НС), относящихся к коренному (n = 12, якуты) и пришлому населению Республики Саха (n = 12, русские). В целом по группе больных НС была выявлена активация воспалительных реакций, что проявлялось усилением спонтанной и индуцированной продукции провоспалительных цитокинов IL-1β, IL-6 и индуцированной продукции IFNγ. По сравнению со здоровыми лицами у больных НС была снижена спонтанная и митоген-индуцированная продукция противовоспалительного IL-4, а индуцированная продукция IL-10 была повышена. Можно предположить, что при НС развивается проатерогенный Th1-иммунный ответ, при одновременном подавлении Th2-клеток. Различия, вы-явленные в этнических группах, дают основание полагать, что тяжесть и распространенность атеро-склеротического поражения, чаще наблюдаемая у больных некоренной национальности ассоцииру-ется с повышением продукции провоспалительных цитокинов IL-1β и IL-6. Ключевые слова: цитокины, атеросклероз, нестабильная стенокардия. Golderova A.S., Nikolaeva I.N., Tarasova V.E., Kozlov V.A. FEATURES OF CYTOKINE PRODUCTION IN PATIENTS WITH UNSTABLE ANGINA: DEPENDENCE ON ETHNICITY IN THE REPUBLIC OF SAKHA (YAKUTIA)Abstract. We investigated levels of spontaneous and mitogen-induced cytokine production (IL-1β, IL-4, IL-6, IL-10 and IFNγ) by peripheral blood cells of 24 men with unstable angina (UA), including indigenous population (n = 12, Yakuts), and a group of Russian migrants to the Republic of Sakha (n = 12). Activation of inflammatory response was revealed in the total group of patients with UA, manifesting by increase of spontaneous and induced production of the pro-inflammatory IL-1β, IL-6 cytokines, and mitogen-induced production of IFNγ. As compared with healthy individuals, spontaneous and induced production of antiinflammatory IL-4 was decreased in UA patients, whereas the mitogen-induced production of IL-10 proved to be enhanced. Therefore, it is highly possible that a pro-atherogenic Th1-immune response is developing during UA, along with suppression of Th2-driving response. The differences revealed for different ethnic groups suggest that severity and prevalence of atherosclerotic disease, which is more common in the non-native patients, is associated with increased production of pro-inflammatory IL-1β and IL-6 cytokines.
The severity of the disease is the main factor for further treatment. Bronchoobstructive syndrome of children is widespread. Early detection of the disease severity and correct treatment eliminate the clinical manifestation of the syndrome and improve the quality of patients life. Criteria of severity, as a rule, serve a certain set of clinical and paraclinical parameters used for different nosological forms. In particular, the decrease in parameters of the function of external respiration is the “gold standard” for assessing the severity. Lung function tests for preschoolers are limited. Clinical respiratory scales may be useful in the evaluation of preschooler. Alternative assessment respiratory function is sometimes used as clinical scale. Numerous studies devoted to the objective assessment of bronchial obstruction syndrome severity. A scientific literature review is dedicated to the analysis to the assessment of the bronchoobstructive syndrome severity degree and the effectiveness of therapy at preschool-aged children.
Multiple sclerosis (MS) is a severe chronic disease of the central nervous system (CNS) that affects young people and quickly leads to disability. Until now, the pathogenesis of this neurological disease, which is the most expensive for society, has not been fully elucidated, and the drugs used to treat MS patients can only slightly suspend but not interrupt the development of the disease. At the same time, the possibilities of diagnosing and treating MS have expanded due to the active study and implementation of neuroimaging, neuroimmunological and neurophysiological methods, and the use of new immunocorrecting genetically engineered drugs.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.
customersupport@researchsolutions.com
10624 S. Eastern Ave., Ste. A-614
Henderson, NV 89052, USA
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Copyright © 2024 scite LLC. All rights reserved.
Made with 💙 for researchers
Part of the Research Solutions Family.